Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
BELLICUM PHARMACEUTICALS, INC (BLCM)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
17 Mar 2020
Fair Richard A.
President and CEO, Director, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
5,000
+100%
5,000
$4.00
$19,998.50
BUY
10 Sep 2019
Fair Richard A.
President and CEO, Director, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
66,561
+6%
4,000
$12.50
$50,000.00
BUY
29 Aug 2019
Ward Shane
Sr. VP and General Counsel, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
18,294
+4%
800
$12.28
$9,821.60
BUY
21 Aug 2019
Fair Richard A.
President and CEO, Director, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
26,561
+8%
2,000
$9.89
$19,780.00
BUY
9 Nov 2018
Stonehouse Jon P
Director
BELLICUM PHARMACEUTICALS, INC
(BLCM)
10,000
+11%
1,000
$45.60
$45,600.00
SELL
4 Sep 2018
Spencer David M.
Chief Technology Officer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
89,939
-1%
1,000
$70.41
$70,413.00
SELL
18 Jul 2018
Spencer David M.
Chief Technology Officer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
99,939
-3%
4,000
$76.28
$305,132.00
SELL
25 May 2018
Musso Alan A
CFO and Treasurer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
26,548
-2%
620.6
$79.71
$49,466.16
SELL
17 Jan 2018
BAKER BROS. ADVISORS LP
10% Owner
BELLICUM PHARMACEUTICALS, INC
(BLCM)
358,671
-19%
88,073.5
$81.98
$7,219,895.00
SELL
9 Jan 2018
Smith Alan K.
EVP, Technical Operations, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
2,087
-2%
48.7
$94.00
$4,577.80
SELL
11 Dec 2017
Musso Alan A
CFO and Treasurer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
31,585
-5%
1,711.7
$93.28
$159,667.38
BUY
27 Nov 2017
Musso Alan A
CFO and Treasurer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
48,702
+1%
620.6
$98.91
$61,382.31
SELL
24 Jul 2017
Smith Alan K.
EVP, Technical Operations, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
1,600
-2%
43.7
$118.50
$5,178.45
SELL
13 Jul 2017
Moseley Ken
Sr. VP and General Counsel, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
491
-73%
1,382.3
$122.60
$169,469.98
SELL
10 Jul 2017
Spencer David M.
Chief Scientific Officer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
138,965
-0%
1,000
$115.40
$115,400.00
SELL
25 May 2017
Musso Alan A
CFO and Treasurer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
54,908
-1%
631.1
$122.41
$77,253.59
BUY
24 Mar 2017
BAKER BROS. ADVISORS LP
10% Owner
BELLICUM PHARMACEUTICALS, INC
(BLCM)
434,760
+3%
16,666.6
$120.00
$1,999,992.00
SELL
7 Feb 2017
Slawin Kevin M.
Director
BELLICUM PHARMACEUTICALS, INC
(BLCM)
294,982
-1%
3,000
$125.41
$376,215.00
SELL
15 Dec 2016
Slawin Kevin M.
Chief Technology Officer, Director, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
324,982
-0%
3,000
$154.51
$463,539.00
SELL
5 Dec 2016
Spencer David M.
Chief Scientific Officer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
146,082
-0%
500
$200.00
$100,000.00
SELL
1 Dec 2016
Spencer David M.
Chief Scientific Officer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
153,115
-0%
500
$175.25
$87,624.33
SELL
1 Dec 2016
Moseley Annemarie
COO/EVP Clinical Development, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
10,984
-18%
2,500
$175.40
$438,504.94
SELL
25 Nov 2016
Musso Alan A
CFO and Treasurer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
61,148
-4%
2,930
$195.10
$571,640.75
SELL
21 Sep 2016
Moseley Ken
Sr. VP and General Counsel, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
344
-77%
1,180
$201.02
$237,202.08
SELL
21 Sep 2016
Spencer David M.
Chief Scientific Officer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
156,082
-1%
1,650
$198.80
$328,016.44
SELL
21 Sep 2016
Slawin Kevin M.
Chief Technology Officer, Director, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
84,206
-2%
2,341.6
$201.18
$471,087.62
SELL
16 Sep 2016
Moseley Ken
Sr. VP and General Counsel, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
344
-39%
220
$200.08
$44,017.94
SELL
16 Sep 2016
Slawin Kevin M.
Chief Technology Officer, Director, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
95,564
-0%
458.4
$200.07
$91,712.98
SELL
16 Sep 2016
Spencer David M.
Chief Scientific Officer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
172,582
-0%
250
$200.11
$50,027.98
SELL
15 Aug 2016
Moseley Ken
Sr. VP and General Counsel, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
344
-22%
100
$200.00
$20,000.00
SELL
15 Aug 2016
Slawin Kevin M.
Chief Technology Officer, Director, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
100,079
-6%
6,700
$193.13
$1,293,943.10
SELL
15 Aug 2016
Spencer David M.
Chief Scientific Officer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
175,082
-0%
100
$200.00
$20,000.00
SELL
27 Jul 2016
Slawin Kevin M.
Chief Technology Officer, Director, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
399,982
-0%
1,500
$150.00
$225,000.00
SELL
27 Jul 2016
Spencer David M.
Chief Scientific Officer, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
176,082
-0%
1,000
$150.00
$150,000.00
SELL
18 Jul 2016
Slawin Kevin M.
Chief Technology Officer, Director, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
134,206
-0%
271.9
$139.92
$38,043.98
SELL
15 Jul 2016
Slawin Kevin M.
Chief Technology Officer, Director, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
136,925
-1%
2,228.1
$137.19
$305,677.50
SELL
2 Jun 2016
Moseley Ken
Sr. VP and General Counsel, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
196
-88%
1,500
$130.00
$195,000.00
SELL
2 Jun 2016
Moseley Annemarie
COO/EVP Clinical Development, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
251
-90%
2,500
$130.00
$325,000.00
SELL
22 Apr 2016
Slawin Kevin M.
Chief Technology Officer, Director, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
159,206
-3%
5,500
$114.27
$628,498.40
SELL
4 Jan 2016
Moseley Annemarie
COO/EVP Clinical Development, Officer
BELLICUM PHARMACEUTICALS, INC
(BLCM)
2,551
-57%
3,500
$190.71
$667,493.94
Home